Clovis Oncology (United Kingdom)

Recent papers from Clovis Oncology (United Kingdom)

1. The Impact of Solar Angle and Cloud Shadows on 3D Reconstruction of Rolling Stock CargoIEEE Access · 2025
2. A super-giant basal cell carcinoma of the scalpOxford Medical Case Reports · 2024
3. Protocol for automated N-glycan sequencing using mass spectrometry and computer-assisted intelligent fragmentationSTAR Protocols · 2024
4. Exploring in-vivo infrared spectroscopy for nail-based diabetes screeningBiomedical Optics Express · 2024
5. Crisis of the Clinical Trials Staff Attrition After the COVID-19 PandemicJCO Oncology Practice · 2023
6. GIPS-Mix for Accurate Identification of Isomeric Components in Glycan Mixtures Using Intelligent Group-Opting StrategyAnalytical Chemistry · 2022
7. What Plasma Can Tell Us When Tissue Cannot: A Case Report of Genomic Testing in mCRPC and Clinical Response to Treatment With the PARP Inhibitor RucaparibFrontiers in Oncology · 2022
8. Effectiveness of Intensive Versus Minimalist Follow-Up Regimen on Survival in Patients With Endometrial Cancer (TOTEM Study): A Randomized, Pragmatic, Parallel Group, Multicenter TrialJournal of Clinical Oncology · 2022
9. Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced CancerEuropean Journal of Drug Metabolism and Pharmacokinetics · 2022
10. A Case Study of Clinical Response to Rucaparib in a Patient with Metastatic Castration-Resistant Prostate Cancer and a RAD51B AlterationCurrent Oncology · 2022
11. Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research StatementJournal of Clinical Oncology · 2022
12. Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259)Journal of Clinical Oncology · 2022
13. An Impacted, Inverted and Rotated Maxillary Central Incisors and Its Surgical Management: A Case Report.PARIPEX-INDIAN JOURNAL OF RESEARCH · 2021
14. Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 StudyClinical Cancer Research · 2021
15. ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancerInternational Journal of Gynecological Cancer · 2021
16. A phase 1, open-label, drug–drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumorsCancer Chemotherapy and Pharmacology · 2021
17. Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairmentCancer Chemotherapy and Pharmacology · 2021
18. NCCN Guidelines Insights: Prostate Cancer, Version 1.2021Journal of the National Comprehensive Cancer Network · 2021
19. Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring aBRCA1orBRCA2Gene AlterationJournal of Clinical Oncology · 2020
20. Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 StudyClinical Cancer Research · 2020